Company
Headquarters: Tokyo, Japan
Employees: 3,696
CEO: Mr. Taisuke Murai
¥55.35 Billion
JPY as of Jan. 1, 2025
US$352.7 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $75.80 B |
| Cencora, Inc. | $47.92 B |
| Cardinal Health, Inc. | $31.29 B |
| Henry Schein, Inc. | $9.32 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $9.01 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Vital KSK Holdings, Inc. has the following listings and related stock indices.
Stock: JPX: 3151 wb_incandescent
Stock: OTC: VKSKF wb_incandescent